Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 159.04MCore Assets
VS
Market
Sector
Industry
History
$ 9.08Close
$ 2.9 - $ 9.34 52-Week Range
Ticker Information
Ticker
XERSCompany Name
XERIS BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQXERIS BIOPHARMA HOLDINGS INC - Core Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XERS - Core Assets Historical data
| Date | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
|---|---|---|---|---|
| 6/30/2025 | $ 334.69M | $ 59.28M | $ 159.04M | $ 116.36M |
| 3/31/2025 | $ 315.45M | $ 58.44M | $ 137.94M | $ 119.07M |
| 12/31/2024 | $ 323.06M | $ 71.62M | $ 129.66M | $ 121.78M |
| 9/30/2024 | $ 321.1M | $ 59.23M | $ 137.38M | $ 124.49M |
| 6/30/2024 | $ 331.73M | $ 57.6M | $ 146.93M | $ 127.2M |
| 3/31/2024 | $ 336.62M | $ 62.69M | $ 144.01M | $ 129.91M |
| 12/31/2023 | $ 322.6M | $ 67.45M | $ 122.53M | $ 132.62M |
| 9/30/2023 | $ 327.78M | $ 46.14M | $ 146.31M | $ 135.33M |
| 6/30/2023 | $ 328.78M | $ 46.17M | $ 144.56M | $ 138.04M |
| 3/31/2023 | $ 321.36M | $ 50.98M | $ 129.62M | $ 140.75M |
Key Performance Insights, Last 5 Years
- XERIS BIOPHARMA HOLDINGS INC's latest trailing twelve months (TTM) Core Assets stands at $ 132.5M.
- Over the past 5 years, XERIS BIOPHARMA HOLDINGS INC's average Core Assets has been $ 115.2M.
- The median Core Assets for XERIS BIOPHARMA HOLDINGS INC during this period was $ 126.08M
- XERIS BIOPHARMA HOLDINGS INC reached its highest Core Assets over the past 5 years at $ 159.04M.
- The lowest Core Assets recorded by XERIS BIOPHARMA HOLDINGS INC in the same timeframe $ 71.77M
XERIS BIOPHARMA HOLDINGS INC's Core Assets vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Core Assets Benchmarks
Similar metrics to Intangibles:
- Tangible Assets - [Calculation] A tangible asset is an asset that has physical substance. Typical examples may include [Inventory], equipment or machinery an property. It is calculated by subtracting intangibles & goodwill [Intangibles] from total [Assets].
- Goodwill & Intangibles to Assets Ratio - [Calculation] The [Intangibles] to [Assets] ratio is used as a company valuation factor by investors. Goodwill & Intangibles represent hard-to-value assets like a company’s brand name, solid customer relations, intellectual property, etc.
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Goodwill and Intangibles - [Balance Sheet] Goodwill and Intangible Assets are a component of [Assets] representing nonphysical assets like goodwill, patents, trademarks, and copyrights; net of accumulated amortization and impairment charges.
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
Definition of Core Assets
[Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].Assets - Intangibles - CashnEq
(=) Core Assets Core Assets for XERIS BIOPHARMA HOLDINGS INC is calculated as follows: Assets [ $ 170.39M ] - Intangibles [ $ 0 ] - CashnEq [ $ 37.89M ]
(=) Core Assets [ $ 132.5M ] XERS - Core Assets, Last 5 years
$ 71.77M
Minimum
Sep 30, 2021
$ 159.04M
Maximum
Jun 30, 2025
$ 115.2M
Average
$ 126.08M
Median
Core Assets Benchmark AnalysisMarket
The chart above depicts the distribution of Core Assets for companies in the Total Stock Market. The average Core Assets of the companies is $ 797.34M with a standard deviation of $ 1.05B.
The following table provides additional summary stats:
Core Assets in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | $ 0 |
| max | $ 4.35B |
| average | $ 797.34M |
| median | $ 287.51M |
| std | $ 1.05B |